Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Supernus Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 239 | 3 | 245 | +9 |
| Shares | 57.0M | 459.7K | 57.1M | +623.9K (+1.1%) |
| Value | $1.57B | $12.7M | $1.65B | +$95.1M (+6.1%) |
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (23)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Integral Health Asset Management, LLC | 220,000 | $6.07M |
| Frontier Capital Management Co LLC | 200,653 | $5.53M |
| HRT Financial LP | 56,739 | $1.56M |
| Chartwell Investment Partners, LLC | 35,139 | $969.0K |
| SG Americas Securities, LLC | 28,999 | $800.0K |
| Wakefield Asset Management LLLP | 20,874 | $575.5K |
| Royce & Associates LP | 18,750 | $516.9K |
| Y-Intercept (Hong Kong) Ltd | 16,131 | $444.7K |
| Squarepoint Ops LLC | 14,551 | $401.2K |
| Man Group plc | – | $312.1K |
| Verition Fund Management LLC | 9,805 | $270.3K |
| Edgestream Partners, L.P. | 9,061 | $249.8K |
| USA Financial Portformulas Corp | 3,438 | $94.8K |
| West Tower Group, LLC | 1,950 | $53.8K |
| Parkside Financial Bank & Trust | 183 | $5.05K |
| GoalVest Advisory LLC | 132 | $3.64K |
| Creative Planning | 128 | $3.53K |
| FinTrust Capital Advisors, LLC | 71 | $1.96K |
| C M Bidwell & Associates Ltd | 61 | $1.68K |
| Sunbelt Securities, Inc. | 35 | $965 |
| Glassman Wealth Services | 16 | $441 |
| American National Bank | 6 | $165 |
| Sofos Investments, Inc. | 1 | $24 |
Not filed for Q4 2023 yet (3)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 426,500 | $11.8M |
| Virginia Retirement Systems Et Al | 20,400 | $562.4K |
| First Republic Investment Management, Inc. | 12,830 | $353.7K |